Class II

Drug Recall: Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02

Ajanta Pharma USA Inc · September 17, 2026

Reason for Recall

Failed Dissolution Specifications: below specification

Distribution

Nationwide in the US.

States Affected

NATIONWIDE

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0010-2027

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.